Brain Advance Access originally published online on January 19, 2005
Brain 2005 128(3):659-670; doi:10.1093/brain/awh381
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients
1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, 2 Central Research Laboratories, School of Medicine, Aichi Medical University and 3 Department of Neuropathology, Institute for Medical Sciences of Aging, Aichi Medical University of Aichi, Japan
Correspondence to: Gen Sobue, MD, PhD, Department of Neurology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho Showa-ku, Nagoya, 466-8550, Japan E-mail: sobueg{at}med.nagoya-u.ac.jp
Spinal and bulbar muscular atrophy (SBMA) is an inherited adult onset motor neuron disease caused by the expansion of a polyglutamine (polyQ) tract within the androgen receptor (AR), affecting only males. The characteristic pathological finding is nuclear inclusions (NIs) consisting of mutant AR with an expanded polyQ in residual motor neurons, and in certain visceral organs. We immunohistochemically examined 11 SBMA patients at autopsy with 1C2, an antibody that specifically recognizes expanded polyQ. Our study demonstrated that diffuse nuclear accumulation of mutant AR was far more frequent and extensive than NIs being distributed in a wide array of CNS nuclei, and in more visceral organs than thus far believed. Mutant AR accumulation was also present in the cytoplasm, particularly in the Golgi apparatus; nuclear or cytoplasmic predominance of accumulation was tissue specific. Furthermore, the extent of diffuse nuclear accumulation of mutant AR in motor and sensory neurons of the spinal cord was closely related to CAG repeat length. Thus, diffuse nuclear accumulation of mutant AR apparently is a cardinal pathogenetic process underlying neurological manifestations, as in SBMA transgenic mice, while cytoplasmic accumulation may also contribute to SBMA pathophysiology.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Suzuki, M. Katsuno, H. Banno, Y. Takeuchi, N. Atsuta, M. Ito, H. Watanabe, F. Yamashita, N. Hori, T. Nakamura, et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA Brain, January 1, 2008; 131(1): 229 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kassubek, F. D Juengling, and A.-D Sperfeld Widespread white matter changes in Kennedy disease: a voxel based morphometry study J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1209 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Adachi, M. Waza, K. Tokui, M. Katsuno, M. Minamiyama, F. Tanaka, M. Doyu, and G. Sobue CHIP Overexpression Reduces Mutant Androgen Receptor Protein and Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model J. Neurosci., May 9, 2007; 27(19): 5115 - 5126. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, E. S. Chevalier-Larsen, D. E. Merry, and M. I. Diamond Soluble Androgen Receptor Oligomers Underlie Pathology in a Mouse Model of Spinobulbar Muscular Atrophy J. Biol. Chem., February 2, 2007; 282(5): 3157 - 3164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Katsuno, H. Adachi, M. Minamiyama, M. Waza, K. Tokui, H. Banno, K. Suzuki, Y. Onoda, F. Tanaka, M. Doyu, et al. Reversible Disruption of Dynactin 1-Mediated Retrograde Axonal Transport in Polyglutamine-Induced Motor Neuron Degeneration. J. Neurosci., November 22, 2006; 26(47): 12106 - 12117. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takeshita, R. Fujinaga, C. Zhao, A. Yanai, and K. Shinoda Huntingtin-associated protein 1 (HAP1) interacts with androgen receptor (AR) and suppresses SBMA-mutant-AR-induced apoptosis Hum. Mol. Genet., August 1, 2006; 15(15): 2298 - 2312. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thomas, J. M. Harrell, Y. Morishima, H.-M. Peng, W. B. Pratt, and A. P. Lieberman Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction Hum. Mol. Genet., June 1, 2006; 15(11): 1876 - 1883. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Atsuta, H. Watanabe, M. Ito, H. Banno, K. Suzuki, M. Katsuno, F. Tanaka, A. Tamakoshi, and G. Sobue Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients Brain, June 1, 2006; 129(6): 1446 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Katsuno, C. Sang, H. Adachi, M. Minamiyama, M. Waza, F. Tanaka, M. Doyu, and G. Sobue Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease PNAS, November 15, 2005; 102(46): 16801 - 16806. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Pulst, N. Santos, D. Wang, H. Yang, D. Huynh, L. Velazquez, and K. P. Figueroa Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset Brain, October 1, 2005; 128(10): 2297 - 2303. [Abstract] [Full Text] [PDF] |
||||





